4591.T
Price:
$77
Market Cap:
$3.64B
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan.
Industry
Biotechnology
IPO Date
2014-09-25
Stock Exchange
JPX
Ticker
4591.T
According to Ribomic Inc.’s latest financial reports and current stock price. The company's current ROE is -32.41%. This represents a change of 298.88% compared to the average of -8.12% of the last 4 quarters.
The mean historical ROE of Ribomic Inc. over the last ten years is -32.71%. The current -32.41% ROE has changed -0.93% with respect to the historical average. Over the past ten years (40 quarters), 4591.T's ROE was at its highest in in the March 2023 quarter at -4.02%. The ROE was at its lowest in in the December 2022 quarter at -13.11%.
Average
-32.71%
Median
-34.68%
Minimum
-39.22%
Maximum
-19.78%
Discovering the peaks and valleys of Ribomic Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 81.48%
Maximum Annual ROE = -19.78%
Minimum Annual Increase = -49.57%
Minimum Annual ROE = -39.22%
| Year | ROE | Change |
|---|---|---|
| 2025 | -33.48% | 10.85% |
| 2024 | -30.20% | -19.90% |
| 2023 | -37.70% | 5.04% |
| 2022 | -35.89% | 81.48% |
| 2021 | -19.78% | -49.57% |
The current ROE of Ribomic Inc. (4591.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-33.79%
5-year avg
-31.41%
10-year avg
-32.71%
Ribomic Inc.’s ROE is greater than Carna Biosciences, Inc. (-101.01%), greater than FunPep Company Limited (-55.89%), greater than Kubota Pharmaceutical Holdings Co., Ltd. (-82.75%), greater than Delta-Fly Pharma, Inc. (-328.10%), greater than D. Western Therapeutics Institute, Inc. (-119.32%), greater than Trans Genic Inc. (-18.55%), less than Immuno-Biological Laboratories Co., Ltd. (17.76%), greater than Kringle Pharma, Inc. (-55.80%), greater than Perseus Proteomics Inc. (-55.88%), greater than PRISM BioLab Co.,LTD (-40.67%),
| Company | ROE | Market cap |
|---|---|---|
| -101.01% | $4.60B | |
| -55.89% | $3.49B | |
| -82.75% | $3.00B | |
| -328.10% | $5.91B | |
| -119.32% | $4.56B | |
| -18.55% | $4.71B | |
| 17.76% | $12.99B | |
| -55.80% | $2.68B | |
| -55.88% | $4.31B | |
| -40.67% | $6.51B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ribomic Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ribomic Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ribomic Inc.'s ROE?
How is the ROE calculated for Ribomic Inc. (4591.T)?
What is the highest ROE for Ribomic Inc. (4591.T)?
What is the 3-year average ROE for Ribomic Inc. (4591.T)?
What is the 5-year average ROE for Ribomic Inc. (4591.T)?
How does the current ROE for Ribomic Inc. (4591.T) compare to its historical average?